Brainstorm Cell Therapeutics (BCLI) Agrees with Massachusetts General Hospital & California Pacific Medical Center to Join in Phase 3 Trial of NurOwn in ALS
Go back to Brainstorm Cell Therapeutics (BCLI) Agrees with Massachusetts General Hospital & California Pacific Medical Center to Join in Phase 3 Trial of NurOwn in ALS| Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) | Delayed: 0.55 +0.02 (3.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.53 | 52 Week High | $3.87 | |||
| Open | $0.52 | 52 Week Low | $1.90 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.52 | EPS | $-0.03 | |||
| Volume | 201,062 | |||||
